• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Propre-save 研究:益生菌和益生元单独或联合应用对极低出生体重儿坏死性小肠结肠炎的影响。

The propre-save study: effects of probiotics and prebiotics alone or combined on necrotizing enterocolitis in very low birth weight infants.

机构信息

Department of Neonatology, Dr Sami Ulus Maternity and Children Research and Training Hospital, Ankara, Turkey.

Department of Neonatology, Dr Sami Ulus Maternity and Children Research and Training Hospital, Ankara, Turkey.

出版信息

J Pediatr. 2015 Mar;166(3):545-51.e1. doi: 10.1016/j.jpeds.2014.12.004. Epub 2015 Jan 13.

DOI:10.1016/j.jpeds.2014.12.004
PMID:25596096
Abstract

OBJECTIVE

To test the efficacy of probiotic and prebiotic, alone or combined (synbiotic), on the prevention of necrotizing enterocolitis (NEC) in very low birth weight (VLBW) infants.

STUDY DESIGN

A prospective, randomized, controlled trial was conducted at 5 neonatal intensive care units in Turkey. VLBW infants (n = 400) were assigned to a control group and 3 study groups that were given probiotic (Bifidobacterium lactis), prebiotic (inulin), or synbiotic (Bifidobacterium lactis plus inulin) added to breastmilk or formula for a maximum of 8 weeks before discharge or death. The primary outcome was NEC (Bell stage ≥2).

RESULTS

The rate of NEC was lower in probiotic (2.0%) and synbiotic (4.0%) groups compared with prebiotic (12.0%) and placebo (18.0%) groups (P < .001). The times to reach full enteral feeding were faster (P < .001), the rates of clinical nosocomial sepsis were lower (P = .004), stays in the neonatal intensive care unit were shorter, (P = .002), and mortality rates were lower (P = .003) for infants receiving probiotics, prebiotics, or synbiotic than controls. The use of antenatal steroid (OR 0.5, 95% CI 0.3-0.9) and postnatal probiotic (alone or in synbiotic) (OR 0.5, 95% CI 0.2-0.8) decreased the risk of NEC, and maternal antibiotic exposure increased this risk (OR 1.9, 95% CI 1.1-3.6).

CONCLUSIONS

In VLBW infants, probiotic (Bifidobacterium lactis) and synbiotic (Bifidobacterium lactis plus inulin) but not prebiotic (inulin) alone decrease NEC.

摘要

目的

检验益生菌和益生元(合称为合生元)单独或联合应用(合生元)对极低出生体重(VLBW)儿坏死性小肠结肠炎(NEC)的预防作用。

研究设计

在土耳其的 5 个新生儿重症监护病房进行了一项前瞻性、随机、对照试验。将 VLBW 婴儿(n=400)分为对照组和 3 个研究组,研究组分别在母乳喂养或配方奶中添加益生菌(长双歧杆菌)、益生元(菊粉)或合生元(长双歧杆菌加菊粉),最大剂量为 8 周,直至出院或死亡。主要结局是 NEC(Bell 分期≥2)。

结果

与益生元组(12.0%)和安慰剂组(18.0%)相比,益生菌组(2.0%)和合生元组(4.0%)的 NEC 发生率较低(P<.001)。达到完全肠内喂养的时间更快(P<.001),临床医院获得性败血症的发生率较低(P=0.004),新生儿重症监护病房的住院时间较短(P=0.002),接受益生菌、益生元或合生元的婴儿死亡率较低(P=0.003)。产前使用类固醇(OR 0.5,95%CI 0.3-0.9)和产后使用益生菌(单独或合生元)(OR 0.5,95%CI 0.2-0.8)降低了 NEC 的风险,而母亲使用抗生素则增加了这一风险(OR 1.9,95%CI 1.1-3.6)。

结论

在 VLBW 婴儿中,益生菌(长双歧杆菌)和合生元(长双歧杆菌加菊粉)而非单独的益生元(菊粉)可降低 NEC 的发生。

相似文献

1
The propre-save study: effects of probiotics and prebiotics alone or combined on necrotizing enterocolitis in very low birth weight infants.Propre-save 研究:益生菌和益生元单独或联合应用对极低出生体重儿坏死性小肠结肠炎的影响。
J Pediatr. 2015 Mar;166(3):545-51.e1. doi: 10.1016/j.jpeds.2014.12.004. Epub 2015 Jan 13.
2
Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants.口服益生菌可降低极低出生体重儿坏死性小肠结肠炎的发病率和严重程度。
Pediatrics. 2005 Jan;115(1):1-4. doi: 10.1542/peds.2004-1463.
3
Probiotics for the prevention of necrotizing enterocolitis in neonates: an 8-year retrospective cohort study.益生菌预防新生儿坏死性小肠结肠炎:一项 8 年回顾性队列研究。
J Clin Pharm Ther. 2013 Dec;38(6):445-9. doi: 10.1111/jcpt.12084. Epub 2013 Jul 19.
4
Efficacy of Saccharomyces boulardii on necrotizing enterocolitis or sepsis in very low birth weight infants: a randomised controlled trial.布拉氏酵母菌对极低出生体重儿坏死性小肠结肠炎或脓毒症的疗效:一项随机对照试验。
Early Hum Dev. 2013 Dec;89(12):1033-6. doi: 10.1016/j.earlhumdev.2013.08.013. Epub 2013 Sep 14.
5
Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial.口服益生菌预防极低出生体重早产儿坏死性小肠结肠炎:一项多中心、随机、对照试验。
Pediatrics. 2008 Oct;122(4):693-700. doi: 10.1542/peds.2007-3007.
6
Probiotic supplementation in mothers of very low birth weight infants.极低出生体重儿母亲补充益生菌
Am J Perinatol. 2014 Jun;31(6):497-504. doi: 10.1055/s-0033-1353490. Epub 2013 Aug 9.
7
Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial.补充牛乳铁蛋白预防极低出生体重儿坏死性小肠结肠炎:一项随机临床试验。
Early Hum Dev. 2014 Mar;90 Suppl 1:S60-5. doi: 10.1016/S0378-3782(14)70020-9.
8
Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial.口服益生菌:凝结芽孢杆菌预防极低出生体重儿坏死性小肠结肠炎的随机对照试验。
Eur J Clin Nutr. 2011 Apr;65(4):434-9. doi: 10.1038/ejcn.2010.278. Epub 2011 Jan 19.
9
Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial.益生菌对极早产儿晚发性败血症的影响:一项随机对照试验。
Pediatrics. 2013 Dec;132(6):1055-62. doi: 10.1542/peds.2013-1339. Epub 2013 Nov 18.
10
Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial.双歧杆菌乳杆菌对极低出生体重儿医院感染发生率的影响:一项随机对照试验。
Neonatology. 2010;98(2):156-63. doi: 10.1159/000280291. Epub 2010 Mar 16.

引用本文的文献

1
Microbiota-Modulating Strategies in Neonates Undergoing Surgery for Congenital Gastrointestinal Conditions: A Narrative Review.先天性胃肠道疾病手术新生儿的微生物群调节策略:一项叙述性综述
Nutrients. 2025 Jul 5;17(13):2234. doi: 10.3390/nu17132234.
2
The panorama of clinical trials for pediatric or adolescent sepsis: current status and future directions.儿科或青少年脓毒症的临床试验全景:现状与未来方向
Int J Surg. 2025 Sep 1;111(9):6491-6493. doi: 10.1097/JS9.0000000000002745. Epub 2025 Jun 12.
3
Incidence of probiotic sepsis and morbidity risk in premature infants: a meta-analysis.
早产儿中益生菌败血症的发生率及发病风险:一项荟萃分析。
Pediatr Res. 2025 May 13. doi: 10.1038/s41390-025-04072-3.
4
Effect of probiotics on necrotizing enterocolitis in preterm infants: a network meta-analysis of randomized controlled trials.益生菌对早产儿坏死性小肠结肠炎的影响:随机对照试验的网状Meta分析
BMC Pediatr. 2025 Mar 27;25(1):237. doi: 10.1186/s12887-025-05469-z.
5
The Impact of Bioactive Molecules from Probiotics on Child Health: A Comprehensive Review.益生菌生物活性分子对儿童健康的影响:全面综述。
Nutrients. 2024 Oct 30;16(21):3706. doi: 10.3390/nu16213706.
6
Effects of synbiotics on necrotizing enterocolitis and full enteral feeding in very low birth weight infants: A double-blind, randomized controlled trial.合生元对极低出生体重儿坏死性小肠结肠炎和完全肠内喂养的影响:一项双盲、随机对照试验。
Medicine (Baltimore). 2024 Sep 13;103(37):e39647. doi: 10.1097/MD.0000000000039647.
7
Probiotic supplementation and risk of necrotizing enterocolitis and mortality among extremely preterm infants-the Probiotics in Extreme Prematurity in Scandinavia (PEPS) trial: study protocol for a multicenter, double-blinded, placebo-controlled, and registry-based randomized controlled trial.益生菌补充剂对极早产儿坏死性小肠结肠炎和死亡率的影响-斯堪的纳维亚极早产儿益生菌(PEPS)试验:一项多中心、双盲、安慰剂对照、基于登记的随机对照试验的研究方案。
Trials. 2024 Apr 12;25(1):259. doi: 10.1186/s13063-024-08088-8.
8
Neonatal Necrotizing Enterocolitis: An Update on Pathophysiology, Treatment, and Prevention.新生儿坏死性小肠结肠炎:发病机制、治疗和预防的最新进展。
Paediatr Drugs. 2024 May;26(3):259-275. doi: 10.1007/s40272-024-00626-w. Epub 2024 Apr 2.
9
Review and Perspectives on for Infants' and Children's Health.婴幼儿健康的回顾与展望
Microorganisms. 2023 Oct 5;11(10):2501. doi: 10.3390/microorganisms11102501.
10
Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants.益生菌预防极早产儿或极低出生体重儿坏死性小肠结肠炎。
Cochrane Database Syst Rev. 2023 Jul 26;7(7):CD005496. doi: 10.1002/14651858.CD005496.pub6.